Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 26,094 | 26,086 | 28,249 | 26,104 | 28,496 |
| Cost of Goods | 14,005 | 13,826 | 14,918 | 14,110 | 14,881 |
| Gross Profit | 12,089 | 12,260 | 13,331 | 11,994 | 13,615 |
| Operating Expenses | 11,347 | 11,761 | 8,868 | 12,183 | 13,197 |
| Operating Income | 747 | 1,325 | 5,381 | -79 | 1,299 |
| Interest Expense | 245 | 130 | 138 | 147 | 152 |
| Other Income | -84 | 35 | -11 | -31 | -74 |
| Pre-tax Income | 418 | 1,230 | 5,232 | -257 | 1,073 |
| Income Tax | 322 | 299 | 1,908 | -124 | 299 |
| Net Income Continuous | 96 | 931 | 3,324 | -133 | 774 |
| Net Income Discontinuous | -282 | -835 | N/A | 0 | N/A |
| Net Income | $-186 | $96 | $1,200 | $-133 | $774 |
| EPS Basic Total Ops | -0.10 | 0.00 | 0.40 | 0.00 | 0.30 |
| EPS Basic Continuous Ops | 0.03 | 0.30 | 1.10 | 0.00 | 0.30 |
| EPS Basic Discontinuous Ops | -0.10 | -0.30 | N/A | 0.00 | N/A |
| EPS Diluted Total Ops | -0.10 | 0.00 | 0.30 | 0.00 | 0.30 |
| EPS Diluted Continuous Ops | 0.03 | 0.30 | 1.00 | 0.00 | 0.30 |
| EPS Diluted Discontinuous Ops | -0.10 | -0.30 | N/A | N/A | N/A |
| EBITDA(a) | $1,767 | $2,393 | $6,432 | $965 | $2,374 |